Testing Status of Toxic equivalency factor evaluation (Dioxin mixture) M960056
CASRN: TEFDIOXINMIX
Synonyms/Common Names
- Dioxin mixture (Toxic equivalency factor evaluation)
- Toxic equivalency factor evaluation (Dioxin mixture)
Secondary:
- 57465-28-8 - 3,3,4,4,5-Pentachlorobiphenyl (PCB 126)
- 57117-31-4 - 2,3,4,7,8-Pentachlorodibenzofuran
- 57117-31-4 - Toxic equivalency factor evaluation (PECDF (Pentachlorodibenzofuran))
- 1746-01-6 - Toxic equivalency factor evaluation (TCDD)
- 57465-28-8 - TEF transgenics (PCB 126)
- 57117-31-4 - TEF transgenics (PECDF)
- 1746-01-6 - TEF transgenics (TCDD)
- 1746-01-6 - 2,3,7,8-Tetrachlorodibenzo-p-dioxin
- 57465-28-8 - Toxic equivalency factor evaluation ((PCB 126) 3,3',4,4',5-pentachlorobiphenyl)
- 1746-01-6 - Transgenic Model Evaluation (2,3,7,8-Tetrachlorodibenzodioxin)
Long-Term Carcinogenicity
- 2 years (Gavage)
(C96007B)
Completed
- TR-526 (NIH Number: 06-4462)
(Peer Review Approval 02/17/2004A )
Toxicology and Carcinogenesis Studies of a Mixture of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) (CASRN 1746-01-6), 2,3,4,7,8-Pentachlorodibenzofuran (PeCDF) (CASRN 57117-31-4), and 3,3',4,4',5-Pentachlorobiphenyl (PCB 126) (CASRN 57465-28-8) in Female Harlan Sprague-Dawley Rats (Gavage Studies) - Rats: Harlan Sprague-Dawley
- Carcinogenesis Results
- Female Rats Clear Evidence
- Dose: Female rats only: 0, (TCDD) 3.3, 7.3, 15.2, or 33 ng/kg; (PECDF) 6.6, 14.5, 30.4, or 66 ng/kg; (PCB 126) 33.3, 73.3, 153, or 333 ng/kg; 100/dose.
- TR-526 (NIH Number: 06-4462)
(Peer Review Approval 02/17/2004A )